Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SOPHiA GENETICS (SOPH) Income towards Parent Company (2020 - 2025)

Historic Income towards Parent Company for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to -$20.0 million.

  • SOPHiA GENETICS's Income towards Parent Company fell 858.55% to -$20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.2 million, marking a year-over-year increase of 2647.96%. This contributed to the annual value of -$62.5 million for FY2024, which is 2087.59% up from last year.
  • As of Q3 2025, SOPHiA GENETICS's Income towards Parent Company stood at -$20.0 million, which was down 858.55% from $22.4 million recorded in Q2 2025.
  • SOPHiA GENETICS's 5-year Income towards Parent Company high stood at $24.7 million for Q2 2022, and its period low was -$25.5 million during Q1 2022.
  • Moreover, its 5-year median value for Income towards Parent Company was -$17.4 million (2025), whereas its average is -$10.3 million.
  • As far as peak fluctuations go, SOPHiA GENETICS's Income towards Parent Company tumbled by 30393.09% in 2021, and later soared by 23420.88% in 2022.
  • SOPHiA GENETICS's Income towards Parent Company (Quarter) stood at -$21.4 million in 2021, then surged by 34.64% to -$14.0 million in 2022, then tumbled by 72.21% to -$24.1 million in 2023, then surged by 37.0% to -$15.2 million in 2024, then plummeted by 32.08% to -$20.0 million in 2025.
  • Its Income towards Parent Company was -$20.0 million in Q3 2025, compared to $22.4 million in Q2 2025 and -$17.4 million in Q1 2025.